Stroke
Conditions
Keywords
Group Clinics, Self Management
Brief summary
The purpose of this study is to test a newly developed outpatient care intervention called SUSTAIN (Systematic Use of Stroke Averting Interventions) for improving delivery of stroke preventive services at Los Angeles County hospitals and to measure the costs of running such an intervention.
Detailed description
Patients randomized to SUSTAIN will participate in group clinics about stroke, given self-management tools about stroke, and will be called by nurse practitioners to coordinate their stroke care. Patients randomized to the control arm will be mailed educational materials about stroke. Subjects in either arm are eligible to receive their usual source of care.
Interventions
Over a period of one year, subjects will participate in two regular stroke clinics, three group clinics, obtain self-management tools, and will receive a series of four scheduled telephone calls by nurse practitioners to review information delivered during the group clinics and help with care coordination. Usual care will also be available.
Educational materials about stroke that will be distributed during the group clinic session will be mailed to these subjects. These materials have been developed by the American Heart Association. Usual care will also be available.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients of LAC+USC, Rancho Los Amigos, Olive View-UCLA, or Harbor-UCLA * Patients who have had an acute transient ischemic attack (TIA) or ischemic stroke or carotid procedure within the last six months * English or Spanish speaking * At least 40 years of age * Capable of giving informed consent (no proxies will be used to obtain consent) * Blood pressure not optimally controlled (\>120/80, at least 72 hours post-stroke)
Exclusion criteria
* Age 39 years or younger * Hemorrhagic stroke * Patients with severe global disability which would preclude him/her from participating in group clinics * Patients with advanced dementia
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Blood Pressure | 12 months | Blood pressure at 12 months will be the primary outcome. Blood pressure will also be measured at baseline and at the 3-month mark to track blood pressure during the entire participation period. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Lipid levels | 12 month | LDL, HDL, triglycerides and total cholesterol will be measured at 12-months. The same measurements will be taken at baseline and at the 3 month mark in order to track measurements throughout the entire participation period. |
| Medication Adherence | 8 months | Medication adherence will be measured in a self-report by the subjects. |
Countries
United States